B
BONS
vs
T
Tel Aviv 355
Over the past 12 months, BONS has significantly outperformed Tel Aviv 355, delivering a return of +90% compared to the Tel Aviv 355's +58% growth.
Stocks Performance
BONS vs Tel Aviv 355
Performance Gap
BONS vs Tel Aviv 355
Performance By Year
BONS vs Tel Aviv 355
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bonus Biogroup Ltd
Glance View
Bonus Biogroup Ltd. is a biotechnology company engaging in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.